Gilles Salles
0000-0002-9541-8666
Publication & Citation Trends
Most Cited Works
Publications
1,706 total
The International Consensus Classification of Mature Lymphoid Neoplasms: a report from the Clinical Advisory Committee PDF
Cited by 1,426
OpenAlex
Axicabtagene ciloleucel in relapsed or refractory indolent non-Hodgkin lymphoma (ZUMA-5): a single-arm, multicentre, phase 2 trial
Cited by 597
OpenAlex
Long-term clinical outcomes of tisagenlecleucel in patients with relapsed or refractory aggressive B-cell lymphomas (JULIET): a multicentre, open-label, single-arm, phase 2 study
Cited by 545
OpenAlex
Acalabrutinib with or without obinutuzumab versus chlorambucil and obinutuzumab for treatment-naive chronic lymphocytic leukaemia (ELEVATE-TN): a randomised, controlled, phase 3 trial PDF
Cited by 596
OpenAlex
Tazemetostat for patients with relapsed or refractory follicular lymphoma: an open-label, single-arm, multicentre, phase 2 trial PDF
Cited by 573
OpenAlex
Tisagenlecleucel in Adult Relapsed or Refractory Diffuse Large B-Cell Lymphoma PDF
Cited by 3,971
OpenAlex
Rituximab in B-Cell Hematologic Malignancies: A Review of 20 Years of Clinical Experience PDF
Cited by 597
OpenAlex
Research Topics
Lymphoma Diagnosis and Treatment
(1167)
Chronic Lymphocytic Leukemia Research
(605)
CAR-T cell therapy research
(402)
Viral-associated cancers and disorders
(239)
CNS Lymphoma Diagnosis and Treatment
(130)
Frequent Co-Authors
Affiliations
Université Claude Bernard Lyon 1
University of Siena
Université Paris-Sud
Université de Tours
Délégation Paris 5